US presidential candidate Bernie Sanders has called on the US Patent and Trademark Office to block extensions to two Gilead Sciences patents covering HIV prevention drugs including Descovy.
Medtronic, the world’s largest medical devices company, is facing a patent infringement lawsuit over its line of artificial heart valves.
New Jersey-based generic drugmaker Rising Pharmaceuticals has admitted to conspiring to fix prices and allocate customers for a generic hypertension drug.
Astellas is set to buy US-based Audentes Therapeutics for approximately $3 billion, as the Japanese pharmaceutical company looks to boost its gene therapy expertise.
Barnes & Thornburg has recruited a new life sciences patent group from the IP boutique Brinks, Gilson & Lione.
Genus Lifesciences is suing pharmaceutical company Mallinckrodt for misusing trade secrets related to a cocaine hydrochloride formulation.
California-based Bio-Rad Laboratories has obtained an injunction from a German court in its long-running dispute with US biotechnology company 10x Genomics.
DLA Piper has strengthened its San Francisco office with the addition of a former Arnold & Porter Kaye Scholer counsel.
Switzerland-based Roche has agreed to acquire Promedior and its portfolio of molecules for serious fibrotic diseases.
A Chinese state-owned chemical firm is suing US crop protection products company Atticus for patent infringement.